Amneal Pharmaceuticals (AMRX) PT Raised to $4 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst, Randall Stanicky, raised the price target on Amneal Pharmaceuticals (NYSE: AMRX) to $4.00 (from $3.00) after updating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
